(Q44622798)

4 December 2017

title

Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus (English)

1 reference

4 December 2017

Efficacy of Sulfonylureas with Insulin in Type 2 Diabetes Mellitus (English)

1 reference

22 March 2024

1 reference

1 reference

Mary U. Kabadi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14565810

22 March 2024

Udaya M. Kabadi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14565810

22 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

http://journals.sagepub.com/doi/pdf/10.1345/aph.1C492

1 reference

http://journals.sagepub.com/doi/full-xml/10.1345/aph.1C492

22 March 2024

1 reference

Annals of Pharmacotherapy

22 March 2024

published in

1 reference

4 December 2017

volume

37

1 reference

4 December 2017

issue

11

1 reference

4 December 2017

page(s)

1572-1576

1 reference

Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide

4 December 2017

cites work

1 reference

Insulin and sulphonylurea in the therapy of type 2 diabetes

21 January 2018

1 reference

Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.

21 January 2018

1 reference

Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents.

21 January 2018

1 reference

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

21 January 2018

1 reference

Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes

21 January 2018

1 reference

Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide

21 January 2018

1 reference

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

21 January 2018

1 reference

The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide

21 January 2018

1 reference

Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group

21 January 2018

1 reference

Incidence of diabetes in American Indians of three geographic areas: the Strong Heart Study

21 January 2018

1 reference

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

21 January 2018

1 reference

Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study Group.

21 January 2018

1 reference

A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients

21 January 2018

1 reference

The insulin-sparing effect of metformin in insulin-treated diabetic patients

21 January 2018

1 reference

Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

21 January 2018

1 reference

The combination of insulin and metformin in treatment of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

Potentiation of the Hepatic Action of Insulin by Chlorpropamide

21 January 2018

1 reference

Sulfonylurea Drugs: Mechanism of Antidiabetic Action and Therapeutic Usefulness

21 January 2018

1 reference

LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective

21 January 2018

1 reference

Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.

21 January 2018

1 reference

Adjuvant therapy with tolazamide and insulin improves metabolic control in type I diabetes mellitus.

21 January 2018

1 reference

More uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 diabetes mellitus: role of enhanced insulin sensitivity.

21 January 2018

1 reference

The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

21 January 2018

Diabète & Métabolisme

5

17

218

Groop L

1991

1 reference

The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with Type 2 diabetes mellitus

22 March 2024

9

1 reference

An insulin dependent effect of chronic tolbutamide administration on the skeletal muscle carbohydrate transport system

22 March 2024

24

1 reference

Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide

22 March 2024

27

1 reference

Sulfonylureas enhance in vivo the effectiveness of insulin in type 1 (insulin dependent) diabetes mellitus

22 March 2024

30

1 reference

Sulfonylureas in insulin-dependent (type I) diabetes: evidence for an extrapancreatic effect in vivo

22 March 2024

31

1 reference

Acute effect of glyburide on insulin sensitivity in type I diabetic patients

22 March 2024

32

1 reference

22 March 2024

Identifiers

DOI

10.1345/APH.1C492

1 reference

4 December 2017

1 reference